[3H]-monoamine uptake inhibition properties of kava pyrones

Planta Medica

Volumn 63, Issue 6, 1997, Pages 548-549

  Seitz, Ulrike ^a   Schüle, Almut ^a   Gleitz, Johannes ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KAWAIN; METHYSTICIN; MONOAMINE OXIDASE INHIBITOR; BIOGENIC AMINE; KAVA; PLANT EXTRACT; PYRONE DERIVATIVE; TRITIUM;

ANXIETY; ARTICLE; DEPRESSION; NORADRENALIN BRAIN LEVEL; SEROTONIN BRAIN LEVEL; SYNAPTOSOME; ANIMAL; BRAIN CORTEX; DRUG ANTAGONISM; HIPPOCAMPUS; IN VITRO STUDY; MEDICINAL PLANT; METABOLISM; RAT;

PIPER METHYSTICUM;

ANIMALS; BIOGENIC MONOAMINES; CEREBRAL CORTEX; HIPPOCAMPUS; KAVA; PLANT EXTRACTS; PLANTS, MEDICINAL; PYRONES; RATS; SYNAPTOSOMES; TRITIUM;

EID: 0031283402     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-957761     Document Type: Article

References (8)

1. Davies, L. P., Drew, C. A., Duffield, P., Johnston, A. R., Jamieson, D. D. (1992) Pharmacol. Toxic. 71, 120-126.
2. Saletu, B., Grünberger, J., Linzmayer, L., Anderer, P. (1989) Hum. Psychopharmacol. 4, 169-190.
3. Gleitz, J., Beile, A., Khan, S., Wilffert, B., Tegtmeier, F. (1993) Brain Res. 611, 286-294.
4. Petterson, E. (1995) Eur. J. Pharmacol. 282, 131-135.
5. Cheng, Y. C., Prusoff, W. H. (1988) Biochem. Pharmacol. 22, 3099-3108.
6. Stanford, S. C. (1996) Trends in Pharmacol. Sci. 17, 150-154.
7. Singh, Y. N. (1992) J. Ethnopharmacol. 37, 13-45.
8. Keledjian, J., Duffield, P. H., Jamieson, R. O., Duffield, A. M. (1988) J. Pharm. Sci. 77, 1003-1006.